You are on page 1of 7

Cell Therapy

Processes and
Advanced Therapy


About us
At 3P Biopharmaceuticals there is a clear
orientation towards achieving results, quality and
continuous improvement.
As a CMO, we offer specialized and highly
customized services tobiotechnology and
pharmaceutical companies.
We are a leading European biotechnology
company with the capacity and resources to
develop bothbiological and cell therapy
products, according to international regulatory

Who we are
3P Biopharmaceuticals benefits from the support of important
institutions,technological and financial partners.
We are an integral part of a privileged environment within the field
ofbiosciencesin Navarra, Spain. 3P Biopharmaceuticals maintains close ties
with the University of Navarra and its different Departments and research
centers such as the Centre for Applied Medical Research of Navarra and with
relevant biotechnological and pharmaceutical companies.
The cooperation with these partners enables 3P Biopharmaceuticals to
develop cutting edge technology and offer comprehensive services of great
added value in the development ofproteinsand other biological molecules.
In addition, the company relies on the active participation and support
from the institutions linked to the Government of Navarra, such as SODENA.

Cell Therapy
3P Biopharmaceuticals is the first Spanish
CMO that offers full service to develop and
manufacture processes and products of
Advanced Therapy
Our staff in the Cell Therapy Department
have broad knowledge and know-how in
stem cells from human bone marrow,
adipose tissue, cornea, and somatic cells
such as osteoblasts, chondrocytes, ephitelial
and endothelial cells, and other cell
populations (hybridomas and tumor cells).
Experience in fields as:
Oncology, etc.

Biosynthesis development
3P BiopharmaceuticalsR&D Department
supports development and optimization of
processes offering batch, high cell density
fed-batch fermentation, and perfusion,
including medium and feeding strategy.
By evaluating critical parameters of the
process, such as related impurities control
from the early beginning, the Process
Validation team ensures successful scaleup and tech transfer.

Analytical development
3P Biopharmaceuticals provides characterization through the
combination of well-known traditional and new proteomic
techniques to obtain scientifically reliable biologics.
Effective development and qualification of analytical and
bioanalytical methods for end product testing (API and final drug
product) is developed in compliance with regulatory requirements.
In-process control, which consists of ensuring effective
monitoring and control for process, product related impurities, and
excipients is performed as well as stability-indicating methods.

Contact us
Polgono Mochol
C/ Mochol 2
31110 Noin
Navarra SPAIN
42.753298, -1.635239

For more info :

Call us at : +34948346480